Novel function of STAT1β in B cells: Induction of cell death by a mechanism different from that of STAT1α

Journal of Leukocyte Biology

Volumn 84, Issue 6, 2008, Pages 1604-1612

  Najjar, Imen ^a,e   Schischmanoff, Pierre Olivier ^a   Baran Marszak, Fanny ^a   Deglesne, Pierre Antoine ^a   Youlyouz Marfak, Ibtissam ^c   Pampin, Mathieu ^b   Feuillard, Jean ^c   Bornkamm, Georg W ^d   Chelbi Alix, Mounira K ^b   Fagard, Remi ^a,f  

^a UNIVERSITÉ PARIS 13   (France)

^b CNRS   (France)

^c UNIVERSITY OF LIMOGES   (France)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e INSTITUT COCHIN   (France)

^f AVICENNE HOSPITAL   (France)

Author keywords

B lymphocytes; Fludarabine; p53

Indexed keywords

PROTEIN P53; PROTEIN STAT1 ALPHA; PROTEIN STAT1 BETA; STAT1 PROTEIN; UNCLASSIFIED DRUG; ISOPROTEIN; MESSENGER RNA; NERVE GROWTH FACTOR RECEPTOR; NERVE PROTEIN; NGFR PROTEIN, HUMAN; STAT1 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN;

ARTICLE; B LYMPHOCYTE; CELL DEATH; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; APOPTOSIS; CELL CULTURE; CELL NUCLEUS; COMPARATIVE STUDY; CYTOPLASM; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

APOPTOSIS; B-LYMPHOCYTES; BLOTTING, WESTERN; CELL NUCLEUS; CELLS, CULTURED; CYTOPLASM; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; NERVE TISSUE PROTEINS; PROTEIN ISOFORMS; RECEPTORS, NERVE GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STAT1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 57149091187     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0508287     Document Type: Article

References (45)

1. Durbin, J. E., Hackenmiller, R., Simon, M. C., Levy, D. E. (1996) Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84, 443-450.
2. Durbin, J. E., Fernandez-Sesma, A., Lee, C. K., Rao, T. D., Frey, A. B., Moran, T. M., Vukmanovic, S., Garcia-Sastre, A., Levy, D. E. (2000) Type I IFN modulates innate and specific antiviral immunity. J. Immunol. 164, 4220-4228.
3. Dupuis, S., Dargemont, C., Fieschi, C., Thomassin, N., Rosenzweig, S., Harris, J., Holland, S. M., Schreiber, R. D., Casanova, J. L. (2001) Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science 293, 300-303.
4. Lee, C. K., Smith, E., Gimeno, R., Gertner, R., Levy, D. E. (2000) STAT1 affects lymphocyte survival and proliferation partially independent of its role downstream of IFN-γ. J. Immunol. 164, 1286-1292.
5. Miller, D. M., Rahill, B. M., Boss, J. M., Lairmore, M. D., Durbin, J. E., Waldman, J. W., Sedmak, D. D. (1998) Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J. Exp. Med. 187, 675-683.
6. Bromberg, J., Darnell Jr., J. E. (2000) The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19, 2468-2473.
7. Ouchi, T., Lee, S. W., Ouchi, M., Aaronson, S. A., Horvath, C. M. (2000) Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-γ target genes. Proc. Natl. Acad. Sci. USA 97, 5208-5213.
8. Sironi, J. J., Ouchi, T. (2004) STAT1-induced apoptosis is mediated by caspases 2, 3, and 7. J. Biol. Chem. 279, 4066-4074.
9. Xu, Y., Kim, S. O., Li, Y., Han, J. (2006) Autophagy contributes to caspase-independent macrophage cell death. J. Biol. Chem. 281, 19179-19187.
10. Kim, H. S., Lee, M. S. (2005) Essential role of STAT1 in caspasein-dependent cell death of activated macrophages through the p38 mitogen-activated protein kinase/STAT1/reactive oxygen species pathway. Mol. Cell. Biol. 25, 6821-6833.
11. Zhang, J. J., Zhao, Y., Chait, B. T., Lathem, W. W., Ritzi, M., Knippers, R., Darnell Jr., J. E. (1998) Ser727-dependent recruitment of MCM5 by Stat1α in IFN-γ-induced transcriptional activation. EMBO J. 17, 6963-6971.
12. Wen, Z., Zhong, Z., Darnell Jr., J. E. (1995) Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82, 241-250.
13. Vinkemeier, U., Cohen, S. L., Moarefi, I., Chait, B. T., Kuriyan, J., Darnell Jr., J. E. (1996) DNA binding of in vitro activated Stat1 α, Stat1 β and truncated Stat1: interaction between NH2-terminal domains stabilizes binding of two dimers to tandem DNA sites. EMBO J. 15, 5616-5626.
14. Zakharova, N., Lymar, E. S., Yang, E., Malik, S., Zhang, J. J., Roeder, R. G., Darnell Jr., J. E. (2003) Distinct transcriptional activation functions of STAT1α and STAT1β on DNA and chromatin templates. J. Biol. Chem. 278, 43067-43073.
15. Baran-Marszak, F., Feuillard, J., Najjar, I., Le Clorennec, C., Bechet, J. M., Dusanter-Fourt, I., Bornkamm, G. W., Raphael, M., Fagard, R. (2004) Differential roles of STAT1α and STAT1β in fludarabine-induced cell cycle arrest and apoptosis in human B cells. Blood 104, 2475-2483.
16. Alvarez, G. R., Zwilling, B. S., Lafuse, W. P. (2003) Mycobacterium avium inhibition of IFN-γ signaling in mouse macrophages: Toll-like receptor 2 stimulation increases expression of dominant-negative STAT1 β by mRNA stabilization. J. Immunol. 171, 6766-6773.
17. Bhardwaj, N., Rosas, L. E., Lafuse, W. P., Satoskar, A. R. (2005) Leishmania inhibits STAT1-mediated IFN-γ signaling in macrophages: increased tyrosine phosphorylation of dominant negative STAT1β by Leishmania mexicana. Int. J. Parasitol. 35, 75-82.
18. Maritano, D., Sugrue, M. L., Tininini, S., Dewilde, S., Strobl, B., Fu, X., Murray-Tait, V., Chiarle, R., Poli, V. (2004) The STAT3 isoforms α and β have unique and specific functions. Nat. Immunol. 5, 401-409.
19. Zhang, Y., Gui, J. (2004) Molecular characterization and IFN signal pathway analysis of Carassius auratus CaSTAT1 identified from the cultured cells in response to virus infection. Dev. Comp. Immunol. 28, 211-227.
20. Huang, P., Plunkett, W. (1991) Action of 9-β-D-arabinofuranosyl-2- fluoroadenine on RNA metabolism. Mol. Pharmacol. 39, 449-455.
21. Rao, V. A., Plunkett, W. (2003) Activation of a p53-mediated apoptotic pathway in quiescent lymphocytes after the inhibition of DNA repair by fludarabine. Clin. Cancer Res. 9, 3204-3212.
22. Leiby, J. M., Snider, K. M., Kraut, E. H., Metz, E. N., Malspeis, L., Grever, M. R. (1987) Phase II trial of 9-β-D-arabinofuranosyl-2- fluoroadenine 5′-monophosphate in non-Hodgkin's lymphoma: prospective comparison of response with deoxycytidine kinase activity. Cancer Res. 47, 2719-2722.
23. Leiby, J. M., Grever, M. R., Staubus, A. E., Neidhart, J. A., Malspeis, L. (1988) Phase I clinical investigation of fludarabine phosphate by a loading-dose and continuous-infusion schedule. J. Natl. Cancer Inst. 80, 447-449.
24. Kavanagh, J. J., Stringer, C. A., Copeland, L. J., Gershenson, D. M., Saul, P. (1986) Phase II trial of fludarabine in patients with epithelial ovarian cancer. Cancer Treat. Rep. 70, 425-426.
25. Keating, M. J., Kantarjian, H., Talpaz, M., Redman, J., Koller, C., Barlogie, B., Velasquez, W., Plunkett, W., Freireich, E. J., McCredie, K. B. (1989) Fludarabine: a new agent with major activity against chronic lymphocytic leukemia. Blood 74, 19-25.
26. Wattel, E., Preudhomme, C., Hecquet, B., Vanrumbeke, M., Quesnel, B., Dervite, I., Morel, P., Fenaux, P. (1994) p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood 84, 3148-3157.
27. Feng, L., Achanta, G., Pelicano, H., Zhang, W., Plunkett, W., Huang, P. (2000) Role of p53 in cellular response to anticancer nucleoside analog-induced DNA damage. Int. J. Mol. Med. 5, 597-604.
28. Rosenwald, A., Chuang, E. Y., Davis, R. E., Wiestner, A., Alizadeh, A. A., Arthur, D. C., Mitchell, J. B., Marti, G. E., Fowler, D. H., Wilson, W. H., Staudt, L. M. (2004) Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response. Blood 104, 1428-1434.
29. Townsend, P. A., Cragg, M. S., Davidson, S. M., McCormick, J., Barry, S., Lawrence, K. M., Knight, R. A., Hubank, M., Chen, P. L., Latchman, D. S., Stephanou, A. (2005) STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage. J. Cell Sci. 118, 1629-1639.
30. Townsend, K. P., Shytle, D. R., Bai, Y., San, N., Zeng, J., Freeman, M., Mori, T., Fernandez, F., Morgan, D., Sanberg, P., Tan, J. (2004) Lovastatin modulation of microglial activation via suppression of functional CD40 expression. J. Neurosci. Res. 78, 167-176.
31. Dupuis, S., Jouanguy, E., Al-Hajjar, S., Fieschi, C., Al-Mohsen, I. Z., Al-Jumaah, S., Yang, K., Chapgier, A., Eidenschenk, C., Eid, P., Al Ghonaium, A., Tufenkeji, H., Frayha, H., Al-Gazlan, S., Al-Rayes, H., Schreiber, R. D., Gresser, I., Casanova, J. L. (2003) Impaired response to interferon-α/ β and lethal viral disease in human STAT1 deficiency. Nat. Genet. 33, 388-391.
32. Nimmerjahn, F., Dudziak, D., Dirmeier, U., Hobom, G., Riedel, A., Schlee, M., Staudt, L. M., Rosenwald, A., Behrends, U., Bornkamm, G. W., Mautner, J. (2004) Active NF-κB signaling is a prerequisite for influenza virus infection. J. Gen. Virol. 85, 2347-2356.
33. Smiley, S. T., Reers, M., Mottola-Hartshorn, C., Lin, M., Chen, A., Smith, T. W., Steele Jr., G. D., Chen, L. B. (1991) Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc. Natl. Acad. Sci. USA 88, 3671-3675.
34. Reers, M., Smith, T. W., Chen, L. B. (1991) J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry 30, 4480-4486.
35. Fagard, R., Mouas, H., Dusanter-Fourt, I., Devillers, C., Bissieres, P., Martin, A., Lenoir, G., VanTan, H., Feuillard, J., Raphael, M. (2002) Resistance to fludarabine-induced apoptosis in Epstein-Barr virus infected B cells. Oncogene 21, 4473-4480.
36. Nepomuceno, R. R., Snow, A. L., Robert Beatty, P., Krams, S. M., Martinez, O. M. (2002) Constitutive activation of Jak/STAT proteins in Epstein-Barr virus-infected B-cell lines from patients with posttransplant lymphoproliferative disorder. Transplantation 74, 396-402.
37. Najjar, I., Baran-Marszak, F., Le Clorennec, C., Laguillier, C., Schischmanoff, O., Youlyouz-Marfak, I., Schlee, M., Bornkamm, G. W., Raphaël, M., Feuillard, J., Fagard, R. (2005) Latent membrane protein 1 regulates STAT1 through NF-κB-dependent interferon secretion in Epstein-Barr virus-immortalized B cells. J. Virol. 79, 4936-4943.
38. Schwartz, J. L., Jordan, R., Evans, H. H., Lenarczyk, M., Liber, H. (2003) The TP53 dependence of radiation-induced chromosome instability in human lymphoblastoid cells. Radiat. Res. 159, 730-736.
39. Alvi, A. J., Austen, B., Weston, V. J., Fegan, C., MacCallum, D., Gianella-Borradori, A., Lane, D. P., Hubank, M., Powell, J. E., Wei, W., Taylor, A. M., Moss, P. A., Stankovic, T. (2005) A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival. Blood 105, 4484-4491.
40. Townsend, P. A., Scarabelli, T. M., Davidson, S. M., Knight, R. A., Latchman, D. S., Stephanou, A. (2004) STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis. J. Biol. Chem. 279, 5811-5820.
41. Siliciano, J. D., Canman, C. E., Taya, Y., Sakaguchi, K., Appella, E., Kastan, M. B. (1997) DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev. 11, 3471-3481.
42. Chapgier, A., Wynn, R. F., Jouanguy, E., Filipe-Santos, O., Zhang, S., Feinberg, J., Hawkins, K., Casanova, J. L., Arkwright, P. D. (2006) Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo. J. Immunol. 176, 5078-5083.
43. Ohmori, Y., Hamilton, T. A. (1997) IL-4-induced STAT6 suppresses IFN-γ-stimulated STAT1-dependent transcription in mouse macrophages. J. Immunol. 159, 5474-5482.
44. Look, D. C., Pelletier, M. R., Tidwell, R. M., Roswit, W. T., Holtzman, M. J. (1995) Stat1 depends on transcriptional synergy with Sp1. J. Biol. Chem. 270, 30264-30267.
45. Stewart, M. D., Choi, Y., Johnson, G. A., Yu-Lee, L. Y., Bazer, F. W., Spencer, T. E. (2002) Roles of Stat1, Stat2, and interferon regulatory factor-9 (IRF-9) in interferon τ regulation of IRF-1. Biol. Reprod. 66, 393-400.